RPG Investment Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,972
Closed -$540K 308
2018
Q1
$540K Sell
1,972
-251
-11% -$77.9K 0.12% 94
2017
Q4
$708K Sell
2,223
-226
-9% -$72.5K 0.17% 85
2017
Q3
$767K Sell
2,449
-274
-10% -$81.1K 0.2% 81
2017
Q2
$739K Sell
2,723
-45
-2% -$11.9K 0.2% 82
2017
Q1
$756K Sell
2,768
-280
-9% -$79.2K 0.22% 80
2016
Q4
$864K Sell
3,048
-317
-9% -$94K 0.29% 71
2016
Q3
$1.05M Buy
3,365
+191
+6% +$56.6K 0.33% 75
2016
Q2
$767K Buy
3,174
+2,084
+191% +$549K 0.21% 87
2016
Q1
$283K Buy
1,090
+110
+11% +$29.1K 0.11% 90
2015
Q4
$300K Buy
+980
New +$282K 0.11% 88

Other funds holding BIIB

RPG Investment Advisory's BIIB Position: Q2 2018 in Review

RPG Investment Advisory sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,972 shares — an estimated $540K sold.

RPG Investment Advisory first reported a position in BIIB in Q4 2015 and held it in 10 quarters. The position peaked at $1.05M in Q3 2016. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • RPG Investment Advisory reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • RPG Investment Advisory sold 1,972 Biogen shares in Q2 2018, an estimated $540K.
  • RPG Investment Advisory first reported a position in Biogen in Q4 2015 and held it in 10 quarters.
  • RPG Investment Advisory's Biogen position peaked at $1.05M in Q3 2016.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on RPG Investment Advisory's 13F filing for Q2 2018, filed 6 Aug 2018.